APA

Otake A., Tsuji D., Taku K., Kawasaki Y., Yokoi M., Nakamori H., Osada M., Matsumoto M., Inoue K., Hirai K. & Itoh K. (20180405). Chemotherapy-induced neutropenia as a prognostic factor in patients with metastatic pancreatic cancer treated with gemcitabine. : European journal of clinical pharmacology.

Chicago

Otake Aki, Tsuji Daiki, Taku Keisei, Kawasaki Yohei, Yokoi Mari, Nakamori Harumi, Osada Marika, Matsumoto Megumi, Inoue Kazuyuki, Hirai Keita and Itoh Kunihiko. 20180405. Chemotherapy-induced neutropenia as a prognostic factor in patients with metastatic pancreatic cancer treated with gemcitabine. : European journal of clinical pharmacology.

Harvard

Otake A., Tsuji D., Taku K., Kawasaki Y., Yokoi M., Nakamori H., Osada M., Matsumoto M., Inoue K., Hirai K. and Itoh K. (20180405). Chemotherapy-induced neutropenia as a prognostic factor in patients with metastatic pancreatic cancer treated with gemcitabine. : European journal of clinical pharmacology.

MLA

Otake Aki, Tsuji Daiki, Taku Keisei, Kawasaki Yohei, Yokoi Mari, Nakamori Harumi, Osada Marika, Matsumoto Megumi, Inoue Kazuyuki, Hirai Keita and Itoh Kunihiko. Chemotherapy-induced neutropenia as a prognostic factor in patients with metastatic pancreatic cancer treated with gemcitabine. : European journal of clinical pharmacology. 20180405.